National Resource Center for Academic Detailing [NaRCAD]
NARCAD
  • Who We Are
    • WHY WE MATTER
    • Our Team
    • Internship Program
    • Testimonials
    • Contact Us
  • LEARNING COURSES
    • Training Series
    • SKILLS LAB
    • ON-DEMAND WEBCASTS
    • Virtual Coaching Sessions
  • Tools
    • Program Planning Hub
    • AD How-To Guides
    • AD Core Toolkits >
      • Inclusivity Toolkit
      • Evaluation Toolkit
      • Opioid Safety Toolkit
      • HIV Prevention Toolkit
      • E-Detailing Toolkit
  • Community
    • COMMUNITY CHECK-INS
    • Peer Connection Program
    • Detailing Community
  • EVENTS
    • CONFERENCE SERIES
    • Present at NaRCAD2025
    • THE CONFERENCE HUB
    • AD Summit Series
    • The AD Summit Hub
  • MEDIA CENTER
    • The Details Blog
    • Podcast Series
    • e-newsletter
    • AD Literature Archives
    • Virtual Bookshelf
  • Who We Are
    • WHY WE MATTER
    • Our Team
    • Internship Program
    • Testimonials
    • Contact Us
  • LEARNING COURSES
    • Training Series
    • SKILLS LAB
    • ON-DEMAND WEBCASTS
    • Virtual Coaching Sessions
  • Tools
    • Program Planning Hub
    • AD How-To Guides
    • AD Core Toolkits >
      • Inclusivity Toolkit
      • Evaluation Toolkit
      • Opioid Safety Toolkit
      • HIV Prevention Toolkit
      • E-Detailing Toolkit
  • Community
    • COMMUNITY CHECK-INS
    • Peer Connection Program
    • Detailing Community
  • EVENTS
    • CONFERENCE SERIES
    • Present at NaRCAD2025
    • THE CONFERENCE HUB
    • AD Summit Series
    • The AD Summit Hub
  • MEDIA CENTER
    • The Details Blog
    • Podcast Series
    • e-newsletter
    • AD Literature Archives
    • Virtual Bookshelf

The DETAILS BLOG

Capturing Stories from the Field: Reflections, Challenges, & Best Practices
subscribe to details

Artificial Intelligence and Academic Detailing

10/23/2023

 
Picture
Jerry Avorn, M.D.
Co-Founder & Special Adviser, NaRCAD

​
Tags: Evidence Based Medicine, Jerry Avorn​

​Following the astonishing debut of AI applications like ChatGPT a year ago, “knowledge workers” (that’s us) have been forced to ponder how much of what we do could be replaced by a very smart set of computer programs. Such applications can already pass medical licensing exams better than many graduates and have gotten remarkably good at reading X-rays and pathology specimens. How soon will AI systems become adept at reviewing the clinical literature and preparing concise, user-friendly summaries, complete with prescribing recommendations?  Not yet, but likely before long.

Picture
​Try it yourself at home: log onto OpenAI.com (it’s free) and ask ChatGPT for advice about medications for diabetes or hypertension or HIV or anything else.  Just be careful about its “hallucinations” – the fact that sometimes AI just makes up wrong stuff. (I prefer the term “confabulation,” also used to describe this well-known phenomenon.) That can be whimsical if you’re a N.Y. Times reporter and ChatGPT advises you to leave your spouse, and it can be very problematic if you’re a lawyer who relies on case law that ChatGPT simply fabricated. (Both actually happened.) But it can be lethal if it involves incorrect clinical recommendations.

​Yet that said, AI is getting smarter every day. If programmed well in the coming years, large language models like ChatGPT or its growing number of competitors could eventually also learn how to gauge prescribers’ current knowledge, attitudes, and practices, and then ask just the right questions to find out why they’re doing what they’re doing, what their concerns are, and what it would take to get them to change.

Picture
Once things mature a bit further, will large health care systems interested in academic detailing and in cost-cutting simply replace humans with AI-AD-bots? After all, they could work 18-hour days, don’t need health care benefits, and can disseminate any message their employer wants. It will be easy replace a recommendation like “SGLT-2 inhibitors in diabetes can reduce cardiovascular and renal disease as well as lower glucose” with: “SGLT-2 inhibitors are extremely expensive and increase our drug budget.  Use metformin or sulfonylureas whenever possible.

Picture
​So if we have a few years to prove that actual people still have a vital role to play in helping practitioners make better decisions, what can we do? 
​
  • First, we should consider and then embrace what makes us fully human in our work: our capacity to bring a critical eye to the clinical literature, and to understand and embrace nuances in the evidence.
  • Second, we can draw on our genuine empathy for the perspective of the practitioner, and an appreciation that that it’s hard to be a front-line clinician. This is a property the bots may eventually be able to simulate, but at the moment still do imperfectly.
  • Third and most important, we can remember to bring to our work a clear moral mission – that good evidence matters a lot, and that patients have to come first.

​Those are values that endure and can distinguish our work from a sophisticated set of algorithms. Best of all, they can’t be changed if whoever is in charge overwrites a few lines of code to maximize some other agenda, or if the algorithms just make stuff up.

Biography. 
Jerry Avorn, MD, Co-Founder & Special Adviser, NaRCAD
Dr. Avorn is Professor of Medicine at Harvard Medical School and Chief Emeritus of the Division of Pharmacoepidemiology and Pharmacoeconomics (DoPE) at Brigham & Women's Hospital. A general internist, geriatrician, and drug epidemiologist,  he pioneered the concept of academic detailing and is recognized internationally as a leading expert on this topic and on optimal medication use, particularly in the elderly. Read More.

Comments are closed.

    Highlighting Best Practices

    We highlight what's working in clinical education through interviews, features, event recaps, and guest blogs, offering clinical educators the chance to share successes and lessons learned from around the country & beyond.

    Search Archives
    by Topic:

    All
    ADvice
    Autism
    Cancer
    Cardiovascular Health
    Chronic Illness
    CME
    Conference
    COVID 19
    Data
    Deprescribing
    Detailing Visits
    Diabetes
    Director's Letter
    E Detailing
    Evaluation
    Evidence Based Medicine
    Expert Trainer Insight Series
    Gender Affirming Care
    Harm Reduction
    Health Disparities
    Health Policy
    Hepatitis C
    HIV/AIDS
    International
    Jerry Avorn
    LOOPR
    Materials Development
    Medications
    Mental Health
    Obesity
    Older Adult Care
    Opioid Safety
    Pediatrics
    Podcast Series
    Practice Facilitation
    PrEP
    Primary Care
    Program Management
    Rural AD Programs
    Sexual Health
    Smoking Cessation
    Stigma
    Substance Use
    Sustainability
    Training
    Vaccinations

    virtual bookshelf
    Looking for additional reading? Check out our Virtual Bookshelf! 

    A collection of curated books that inspire, educate, and empower.

​NaRCAD is a program of the Boston Medical Center, founded at Brigham & Women's Hospital, Division of Pharmacoepidemiology & Pharmacoeconomics.
​Privacy Notice
Proudly powered by Weebly
Photo from Marco Verch (CC BY 2.0)